José Baselga, MD, Ph.D., co-editor of the discovery of cancer and head of hematology / oncology at Massachusetts General Hospital, has organized a conference on this research.New research published in Cancer Discovery, the new journal of the American Association for Cancer Research, the details of a major project on the genetic profile has identified numerous shortcomings in breast cancer cells.

Bernards Ren, Ph.D., professor of molecular carcinogenesis at the Cancer Institute in Amsterdam in the Netherlands.

We have already had considerable success in identifying genes that are highly active in breast cancer, then the block, such as HER2. Our new work shows that there are many other ways to do this using some of the inherent weaknesses found in breast cancer cells, said Ashworth.

‘Children and young people should be at the heart of the delivery of health services. A system that regularly fails the most vulnerable children can not be allowed to continue.

Christopher Lord, Ph.D., principal staff of the Center for Breakthrough Breast Cancer Research at the Institute of Cancer Research in London, and

Alan Ashworth, Ph.D., CEO of the Institute of Cancer Research in London;

We have shown that the profiling allows comprehensive functional classification of breast cancer in subgroups defined subtypes, Ashworth said.

Alan Ashworth, Ph.D., CEO of the Institute of Cancer Research in London, said that the search for a more personalized approach in the treatment of cancer has led him and colleagues to identify genes in breast cancer cells that are totally dependent. Ashworth and his colleague Christopher Lord, Ph.

, see this as the first step toward developing better treatments for the disease.